Severe abnormal behavior incidence after administration of neuraminidase inhibitors using the national database of medical claims

Emergency Use Authorization for Intravenous Peramivir: Evaluation of Safety in the Treatment of Hospitalized Patients Infected With 2009 H1N1 Influenza A Virus

Alfred Sorbello, S. Christopher Jones, W. Carter et al. · Clinical Infectious Diseases · 2012 · 51 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Peramivir Use for Treatment of Hospitalized Patients With Influenza A(H1N1)pdm09 Under Emergency Use Authorization, October 2009-June 2010

Yan Yu, Shikha Garg, Patricia Yu et al. · Clinical Infectious Diseases · 2012 · 41 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Life-Threatening Abnormal Behavior Incidence in 10–19 Year Old Patients Administered Neuraminidase Inhibitors

Yuuki Nakamura, Tamie Sugawara, Yasushi Ohkusa et al. · PLoS ONE · 2015 · 17 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Abnormal behavior during influenza in Japan during the last seven seasons: 2006–2007 to 2012–2013

Yuuki Nakamura, Tamie Sugawara, Yasushi Ohkusa et al. · Journal of Infection and Chemotherapy · 2014 · 17 citations

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety evaluation of laninamivir octanoate hydrate through analysis of adverse events reported during early post-marketing phase vigilance

Takashi Nakano, Akihisa Okumura, Takuya Tanabe et al. · Scandinavian Journal of Infectious Diseases · 2013 · 16 citations

Pharmacy, Pharmacology, Pharmacotherapy +17